Since IL-17 and IL-23 are inflammatory cytokines, high concentrations of these markers arethought to be associated with the severity of HT and the progression of the disease, based on the autoimmune association between thyroid hormones, TPO, nesfatin-1 and neopterin. This evidence concerns the gene NUCB2 and hematocrit.